SLB invites startups, entrepreneurs, and early‑stage ventures to submit proposals for commercial applications of fluorescent nanodiamonds (FNDs) and associated technologies that leverage their unique optical and quantum‑sensing properties. Application deadline: May 10, 2026.
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
James J. Collins, Termeer Professor of Medical Engineering & Science, MIT & co-founder of Enbiotix, Synlogic, and multiple other startups fostered in the Collins lab, including Sample6.